메뉴 건너뛰기




Volumn 14, Issue 5, 2003, Pages 350-355

Hydroxyurea in combination with didanosine and stavudine in antiretroviral-experienced HIV-infected subjects with a review of the literature

Author keywords

Antiretroviral therapy; Didanosine; Hydroxyurea; Review

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; HYDROXYUREA; LAMIVUDINE; STAVUDINE; ZALCITABINE; ZIDOVUDINE;

EID: 0038475908     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646203321605576     Document Type: Review
Times cited : (11)

References (23)
  • 1
    • 0026704779 scopus 로고
    • The evolution of hydroxyurea therapy in chronic myelogenous leukemia
    • Kennedy BJ. The evolution of hydroxyurea therapy in chronic myelogenous leukemia. Semin Onc 1992;19(Suppl 9):21-6
    • (1992) Semin Onc , vol.19 , Issue.SUPPL. 9 , pp. 21-26
    • Kennedy, B.J.1
  • 2
    • 0026778383 scopus 로고
    • Mechanism of action of hydroxyurea
    • Yarbro JW. Mechanism of action of hydroxyurea. Semin Onc 1992;19:(Suppl 9):1-10
    • (1992) Semin Onc , vol.19 , Issue.SUPPL. 9 , pp. 1-10
    • Yarbro, J.W.1
  • 3
    • 0027377963 scopus 로고
    • Low levels of deoxynucleotides in peripheral blood lymphocytes: A strategy to inhibit human immunodeficiency virus type 1 replication
    • Gao W-Y, Cara A, Gallo RC, Lori R. Low levels of deoxynucleotides in peripheral blood lymphocytes: A strategy to inhibit human immunodeficiency virus type 1 replication. Proc Natl Acad Sci 1993;90:8925-8
    • (1993) Proc Natl Acad Sci , vol.90 , pp. 8925-8928
    • Gao, W.-Y.1    Cara, A.2    Gallo, R.C.3    Lori, R.4
  • 4
    • 0027948936 scopus 로고
    • Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication
    • Lori F, Malykh A, Cara A, et al. Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication. Science 1994;266:801-5
    • (1994) Science , vol.266 , pp. 801-805
    • Lori, F.1    Malykh, A.2    Cara, A.3
  • 5
    • 0029086336 scopus 로고
    • Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2′,3′-dideoxynucleoside activities against replication of human immunodeficiency virus
    • Gao W-Y, Johns DG, Chokekijchai S, Mitsuya H. Disparate actions of hydroxyurea in potentiation of purine and pyrimidine 2′,3′-dideoxynucleoside activities against replication of human immunodeficiency virus. Proc Natl Acad Sci 1995;92:8333-7
    • (1995) Proc Natl Acad Sci , vol.92 , pp. 8333-8337
    • Gao, W.-Y.1    Johns, D.G.2    Chokekijchai, S.3    Mitsuya, H.4
  • 6
    • 0027976787 scopus 로고
    • Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools
    • Meyerhans A, Vartanian J-P, Hultgren C, et al. Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools. J Virol 1994;68:535-40
    • (1994) J Virol , vol.68 , pp. 535-540
    • Meyerhans, A.1    Vartanian, J.-P.2    Hultgren, C.3
  • 7
    • 7144257857 scopus 로고    scopus 로고
    • A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection
    • Rutschmann OT, Opravil M, Iten A, et al. A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. AIDS 1998;12:F71-7
    • (1998) AIDS , vol.12
    • Rutschmann, O.T.1    Opravil, M.2    Iten, A.3
  • 9
    • 0033118835 scopus 로고    scopus 로고
    • Management of sickle cell disease
    • Steinberg MH. Management of sickle cell disease. N Engl J Med 1999;340:1021-30
    • (1999) N Engl J Med , vol.340 , pp. 1021-1030
    • Steinberg, M.H.1
  • 10
    • 0030055872 scopus 로고    scopus 로고
    • Treatment of human immunodeficiency virus infection with hydroxyurea: Virologic and clinical evaluation
    • Giacca M, Zanussi S, Comar M, et al. Treatment of human immunodeficiency virus infection with hydroxyurea: virologic and clinical evaluation. J Infect Dis 1996;174:204-9
    • (1996) J Infect Dis , vol.174 , pp. 204-209
    • Giacca, M.1    Zanussi, S.2    Comar, M.3
  • 12
    • 0030956535 scopus 로고    scopus 로고
    • A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus disease receiving chronic didanosine therapy: Canadian HIV Trials Network Protocol 080
    • Montaner JSC, Zala C, Conway B, et al. A pilot study of hydroxyurea among patients with advanced human immunodeficiency virus disease receiving chronic didanosine therapy: Canadian HIV Trials Network Protocol 080. J Infect Dis 1997;175:801-6
    • (1997) J Infect Dis , vol.175 , pp. 801-806
    • Montaner, J.S.C.1    Zala, C.2    Conway, B.3
  • 13
    • 0029086733 scopus 로고
    • Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1 infected individuals
    • Biron F, Lucht F, Peyramond D, et al. Anti-HIV activity of the combination of didanosine and hydroxyurea in HIV-1 infected individuals. AIDS Res Hum Retrovir 1995;10: 36-40
    • (1995) AIDS Res Hum Retrovir , vol.10 , pp. 36-40
    • Biron, F.1    Lucht, F.2    Peyramond, D.3
  • 14
    • 0037708198 scopus 로고    scopus 로고
    • Antiviral activity and CD4 count responses in patients treated with efavirenz, stavudine, and didanosine, plus hydroxyurea or placebo: 48 Week final results from the 3D study
    • abstract no. LB-09
    • Murphy RL, Katlama C, Bedsey E, et al. Antiviral activity and CD4 count responses in patients treated with efavirenz, stavudine, and didanosine, plus hydroxyurea or placebo: 48 week final results from the 3D study (abstract no. LB-09). In: Program and abstracts of the 1st International AIDS Society Conference on HIV Pathogenesis and Treatment 2001:323
    • (2001) Program and Abstracts of the 1st International AIDS Society Conference on HIV Pathogenesis and Treatment , pp. 323
    • Murphy, R.L.1    Katlama, C.2    Bedsey, E.3
  • 15
    • 0035958764 scopus 로고    scopus 로고
    • Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression
    • Havlir DV, Gilbert PB, Bennett K, et al. Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression. AIDS 2001;15:1379-88
    • (2001) AIDS , vol.15 , pp. 1379-1388
    • Havlir, D.V.1    Gilbert, P.B.2    Bennett, K.3
  • 16
    • 0033914469 scopus 로고    scopus 로고
    • In vivo antagonism with zidovudine plus stavudine combination therapy
    • Havlir DV, Tierney C, Friedland GH, et al. In vivo antagonism with zidovudine plus stavudine combination therapy. J Infect Dis 2000;182:321-5
    • (2000) J Infect Dis , vol.182 , pp. 321-325
    • Havlir, D.V.1    Tierney, C.2    Friedland, G.H.3
  • 17
    • 0030831543 scopus 로고    scopus 로고
    • Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance
    • Lori F, Malykh AG, Foli A, et al. Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance. AIDS Res Hum Retrovir 1997;13:1403-9
    • (1997) AIDS Res Hum Retrovir , vol.13 , pp. 1403-1409
    • Lori, F.1    Malykh, A.G.2    Foli, A.3
  • 18
    • 0026465275 scopus 로고
    • Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine
    • Gu Z, Gao Q, Li X, Parniak MA, Wainberg MA. Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2′,3′-dideoxyinosine and 2′,3′-dideoxycytidine. J Virol 1992;66:7128-35
    • (1992) J Virol , vol.66 , pp. 7128-7135
    • Gu, Z.1    Gao, Q.2    Li, X.3    Parniak, M.A.4    Wainberg, M.A.5
  • 19
    • 0028607429 scopus 로고
    • Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy
    • Kozal MJ, Kroodsma K, Winters MA, et al. Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy. Ann Intern Med 1994;121:263-8
    • (1994) Ann Intern Med , vol.121 , pp. 263-268
    • Kozal, M.J.1    Kroodsma, K.2    Winters, M.A.3
  • 20
    • 0032817241 scopus 로고    scopus 로고
    • A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance
    • Larder BA, Bloor S, Kemp SD, et al. A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance. Antimicrob Agents Chemother 1999;43:1961-7
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 1961-1967
    • Larder, B.A.1    Bloor, S.2    Kemp, S.D.3
  • 21
    • 0030840407 scopus 로고    scopus 로고
    • Mutations in the pol gene of human immunodeficiency virus type 1 in infected patients receiving didanosine and hydroxyurea combination therapy
    • De Antoni A, Foli A, Lisziewicz J, Lori F. Mutations in the pol gene of human immunodeficiency virus type 1 in infected patients receiving didanosine and hydroxyurea combination therapy. J Infect Dis 1997;176:899-903
    • (1997) J Infect Dis , vol.176 , pp. 899-903
    • De Antoni, A.1    Foli, A.2    Lisziewicz, J.3    Lori, F.4
  • 22
    • 0032854838 scopus 로고    scopus 로고
    • Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolates
    • Palmer S, Shafer RW, Merigan TC. Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolates. Antimicrob Agents Chemother 1999;43:2046-50
    • (1999) Antimicrob Agents Chemother , vol.43 , pp. 2046-2050
    • Palmer, S.1    Shafer, R.W.2    Merigan, T.C.3
  • 23
    • 0034056306 scopus 로고    scopus 로고
    • A randomized study of the safety and antiretroviral activity of hydroxyurea combined with didanosine in persons infected with human immunodeficiency virus type 1
    • American Foundation for AIDS Research Community-Based Clinical Trials Network
    • Hellinger JA, Iwane MK, Smith JJ, et al. A randomized study of the safety and antiretroviral activity of hydroxyurea combined with didanosine in persons infected with human immunodeficiency virus type 1. American Foundation for AIDS Research Community-Based Clinical Trials Network. J Infect Dis 2000;181:540-7
    • (2000) J Infect Dis , vol.181 , pp. 540-547
    • Hellinger, J.A.1    Iwane, M.K.2    Smith, J.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.